After the bell today a Form 144 filing (get it here in the April 30 link) was released concerning everybody’s favorite pink sheet bioturd, Coronacrapper extraordinaire, Cytodyn (CYDY).
1175680 CytoDynInc NaderPourhassan 20200430
Yes, CEO Nader “The Nadir” Pourhassan sold 4.8mm shares on 30 April, while telling the world the amazing wonders of Cytodyn‘s ancient one time AIDS-then cancer-now-coronavirus drug. Said the company that day:
Of course the NEJM letter about those renal transplant patients shows the results of leronlimab were nothing short of, well, nothing.
The shares did see very strong stock promotion though. Strong enough for The Nadir to dump all that stock, that appears to be at zero basis. Nice work.
THE CONTENT CONTAINED IN THIS BLOG REPRESENTS ONLY THE OPINIONS OF THE AUTHOR. THE AUTHOR MAY HOLD EITHER LONG OR SHORT POSITIONS IN SECURITIES OF VARIOUS COMPANIES DISCUSSED IN THE BLOG. THIS COMMENTARY IN NO WAY CONSTITUTES INVESTMENT ADVICE, AND SHOULD NEVER BE RELIED ON IN MAKING AN INVESTMENT DECISION, EVER. THIS BLOG IS NOT A SOLICITATION OF BUSINESS: ALL INQUIRIES WILL BE IGNORED. THE CONTENT HEREIN IS INTENDED SOLELY FOR THE ENTERTAINMENT OF THE READER, AND THE AUTHOR.
Can you provide a link to this SEC filing — it is not showing up in the SEC searches.
Did you bother clicking on the either one of the two hyperlinks in the blog post you just commented on which lead right to the filings? – Editor
A friend of mine has a relative who is a doctor at St. Elizabeth Hospital in Boston. He contracted virus and got intubated. After receiving Leronlimab, he recovered and got discharged. So this medication worked for Covid-19 patients.
[1. Glad to hear your freind’s relative is healthy. 2. You are falling prey to one of the oldest tricks in the con artist playbook and a common flaw in thinking, the post hoc ergo propter hoc fallacy. 3. There is no record of St. Elizabeth’s being part of any leronlimab clinical trial. Check for yourself here and here and the list of all of their Covid-19 trials with leronlimab (all 2 of them) here. – Editor]
With an eIND program, investigational drugs can be provided to a patient regardless of the hospital they are in. There have been 75 eIND patients dosed with leronlimab.